| pubmed-article:12012138 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12012138 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:12012138 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:12012138 | lifeskim:mentions | umls-concept:C0221102 | lld:lifeskim |
| pubmed-article:12012138 | lifeskim:mentions | umls-concept:C0232804 | lld:lifeskim |
| pubmed-article:12012138 | lifeskim:mentions | umls-concept:C1524119 | lld:lifeskim |
| pubmed-article:12012138 | lifeskim:mentions | umls-concept:C0011847 | lld:lifeskim |
| pubmed-article:12012138 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:12012138 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:12012138 | pubmed:dateCreated | 2002-5-15 | lld:pubmed |
| pubmed-article:12012138 | pubmed:abstractText | To determine the effect of short-term administration of diclofenac-colestyramine on glomerular filtration rate (GFR), renal plasma flow (RPF) and urinary excretion of prostanoids in patients with type-2 diabetes without and with impaired renal function. | lld:pubmed |
| pubmed-article:12012138 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12012138 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12012138 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12012138 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12012138 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12012138 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12012138 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12012138 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12012138 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12012138 | pubmed:month | May | lld:pubmed |
| pubmed-article:12012138 | pubmed:issn | 0031-6970 | lld:pubmed |
| pubmed-article:12012138 | pubmed:author | pubmed-author:MerkelUU | lld:pubmed |
| pubmed-article:12012138 | pubmed:author | pubmed-author:HoffmannAA | lld:pubmed |
| pubmed-article:12012138 | pubmed:author | pubmed-author:SeyberthH WHW | lld:pubmed |
| pubmed-article:12012138 | pubmed:author | pubmed-author:HaertingJJ | lld:pubmed |
| pubmed-article:12012138 | pubmed:author | pubmed-author:SchweerHH | lld:pubmed |
| pubmed-article:12012138 | pubmed:author | pubmed-author:FarkerKK | lld:pubmed |
| pubmed-article:12012138 | pubmed:author | pubmed-author:EggersRR | lld:pubmed |
| pubmed-article:12012138 | pubmed:author | pubmed-author:MüllerU AUA | lld:pubmed |
| pubmed-article:12012138 | pubmed:author | pubmed-author:MadaneS JSJ | lld:pubmed |
| pubmed-article:12012138 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12012138 | pubmed:volume | 58 | lld:pubmed |
| pubmed-article:12012138 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12012138 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12012138 | pubmed:pagination | 85-91 | lld:pubmed |
| pubmed-article:12012138 | pubmed:dateRevised | 2010-3-23 | lld:pubmed |
| pubmed-article:12012138 | pubmed:meshHeading | pubmed-meshheading:12012138... | lld:pubmed |
| pubmed-article:12012138 | pubmed:meshHeading | pubmed-meshheading:12012138... | lld:pubmed |
| pubmed-article:12012138 | pubmed:meshHeading | pubmed-meshheading:12012138... | lld:pubmed |
| pubmed-article:12012138 | pubmed:meshHeading | pubmed-meshheading:12012138... | lld:pubmed |
| pubmed-article:12012138 | pubmed:meshHeading | pubmed-meshheading:12012138... | lld:pubmed |
| pubmed-article:12012138 | pubmed:meshHeading | pubmed-meshheading:12012138... | lld:pubmed |
| pubmed-article:12012138 | pubmed:meshHeading | pubmed-meshheading:12012138... | lld:pubmed |
| pubmed-article:12012138 | pubmed:meshHeading | pubmed-meshheading:12012138... | lld:pubmed |
| pubmed-article:12012138 | pubmed:meshHeading | pubmed-meshheading:12012138... | lld:pubmed |
| pubmed-article:12012138 | pubmed:meshHeading | pubmed-meshheading:12012138... | lld:pubmed |
| pubmed-article:12012138 | pubmed:meshHeading | pubmed-meshheading:12012138... | lld:pubmed |
| pubmed-article:12012138 | pubmed:meshHeading | pubmed-meshheading:12012138... | lld:pubmed |
| pubmed-article:12012138 | pubmed:meshHeading | pubmed-meshheading:12012138... | lld:pubmed |
| pubmed-article:12012138 | pubmed:meshHeading | pubmed-meshheading:12012138... | lld:pubmed |
| pubmed-article:12012138 | pubmed:meshHeading | pubmed-meshheading:12012138... | lld:pubmed |
| pubmed-article:12012138 | pubmed:meshHeading | pubmed-meshheading:12012138... | lld:pubmed |
| pubmed-article:12012138 | pubmed:meshHeading | pubmed-meshheading:12012138... | lld:pubmed |
| pubmed-article:12012138 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:12012138 | pubmed:articleTitle | Effects of short-term treatment with diclofenac-colestyramine on renal function and urinary prostanoid excretion in patients with type-2 diabetes. | lld:pubmed |
| pubmed-article:12012138 | pubmed:affiliation | Institute of Clinical Pharmacology, Friedrich Schiller University Jena, Dornburger Strasse 159, 07740 Jena, Germany. katrin.farker@med.uni-jena.de | lld:pubmed |
| pubmed-article:12012138 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12012138 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:12012138 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:12012138 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
